Business Insider

Apricus Begins Discussions With Interested Parties For U.S. Vitaros Rights

(RTTNews) - Apricus Biosciences, Inc. (APRI) announced the outcome of its end-of-review meeting with the U.S. FDA on the New Drug Application for Vitaros (alprostadil), a topical cream for the ...
Business Insider

Apricus Biosciences Files NDA Resubmission for Vitaros™Approval Decision Expected in First Quarter 2018

SAN DIEGO, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reported that it ...
Nasdaq

Apricus Up after Regaining Vitaros U.S. Rights from Allergan

Apricus Biosciences, Inc. 's APRI shares gained 7.7% after the company announced that it has entered into a license agreement with Allergan AGN under which it will regain the U.S. development and ...
Seeking Alpha

National Phase Approvals Granted In Ireland And The Netherlands For Apricus Biosciences' (APRI) Vitaros

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Pharmaceutical company Apricus Biosciences announced that both the Irish Medicines Board and the Netherlands' ...